JPH09503774A - 閉経直前及び閉経後の女性に対するホルモン置換療法用の黄体ホルモン拮抗物質及び部分的アゴニスト作用を有する抗エストロゲンの組合わせ - Google Patents
閉経直前及び閉経後の女性に対するホルモン置換療法用の黄体ホルモン拮抗物質及び部分的アゴニスト作用を有する抗エストロゲンの組合わせInfo
- Publication number
- JPH09503774A JPH09503774A JP7511310A JP51131095A JPH09503774A JP H09503774 A JPH09503774 A JP H09503774A JP 7511310 A JP7511310 A JP 7511310A JP 51131095 A JP51131095 A JP 51131095A JP H09503774 A JPH09503774 A JP H09503774A
- Authority
- JP
- Japan
- Prior art keywords
- estrogen
- hydroxy
- phenyl
- replacement therapy
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.閉経直前及び閉経後の女性に対するホルモン置換療法(HRT)のための薬 剤の製造を目的とする少なくとも1つの黄体ホルモン拮抗(PA)化合物及び部分 的にはアゴニスト作用をも有する少なくと 2.請求の範囲第1項に記載の黄体ホルモン拮抗(PA)作用を有する化合物と しての11β−〔(4−N,N−ジメチルアミノ)−フェニル〕−17β−ヒドロキ シ−17α−プロピニル−4,9(10)−エストラジエシ−3−オンまたは11β− (4−ジメチルアミノ)−17α−ヒドロキシ−17β−(3−ヒドロキシ−プロピ ル−13α−メチル−4,9−ゴナジエン−3−オンの利用。 る化合物としての(Z)−2−〔p−(1,2−ジフェニル−1−ブテニル)− フェノキシ〕−N,N−ジメチル−エチルアミン、1,2−〔4−(6−メトキ シ−2−フェニル−3,4−ジヒドロ−1−ナフチル)−フェノキシ〕−エチル −ピロリドン、塩酸塩、1−〔p−(2−ジエチルアミノエトキシ)−フェニル 〕−2−(p−メトキシフェニル)−1−フェニルエタノール、または6−ヒド ロキシ−2−(p−ヒドロキシフェニル)ベンゾ〔b〕チエン−3−イル−P− (2−ピペリジノエトキシ)フェニルケトン、塩酸塩の利用。 −ジメチルアミノ)−17α−ヒドロキシ−17β−(3−ヒドロキシ−プロピル) −13α−メチル−4,9−ゴナジエン−3−オン(PA)及び(Z)−2−〔p− (1,2−ジフェニル−1−ブテニル)−フェノキシ〕−N,N−ジメチル−エ チルアミンの利用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4335876.4 | 1993-10-17 | ||
DE4335876A DE4335876A1 (de) | 1993-10-17 | 1993-10-17 | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
PCT/EP1994/003408 WO1995011013A2 (de) | 1993-10-17 | 1994-10-17 | Kombination von progesteronantagonisten und antiöstrogenen mit partialer agonistischer wirkung für die hormonsubstitutions-therapie für peri- und postmenopausale frauen |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09503774A true JPH09503774A (ja) | 1997-04-15 |
Family
ID=6500646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7511310A Withdrawn JPH09503774A (ja) | 1993-10-17 | 1994-10-17 | 閉経直前及び閉経後の女性に対するホルモン置換療法用の黄体ホルモン拮抗物質及び部分的アゴニスト作用を有する抗エストロゲンの組合わせ |
Country Status (19)
Country | Link |
---|---|
US (1) | US5719136A (ja) |
EP (1) | EP0723439B1 (ja) |
JP (1) | JPH09503774A (ja) |
KR (1) | KR100348116B1 (ja) |
CN (1) | CN1128613C (ja) |
AT (1) | ATE196251T1 (ja) |
AU (1) | AU691839B2 (ja) |
CA (1) | CA2174327C (ja) |
CZ (1) | CZ285690B6 (ja) |
DE (2) | DE4335876A1 (ja) |
DK (1) | DK0723439T3 (ja) |
ES (1) | ES2150503T3 (ja) |
GR (1) | GR3035054T3 (ja) |
HU (1) | HUT74430A (ja) |
NO (1) | NO308584B1 (ja) |
NZ (1) | NZ274510A (ja) |
PT (1) | PT723439E (ja) |
SK (1) | SK281312B6 (ja) |
WO (1) | WO1995011013A2 (ja) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE214269T1 (de) * | 1997-06-27 | 2002-03-15 | Akzo Nobel Nv | Oral anzuwendende flüssige arzneilösung |
WO1999059969A1 (en) * | 1998-05-15 | 1999-11-25 | American Home Products Corporation | Compositions comprising 2-phenyl-indole compounds and estrogen formulations |
US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
AU777770C (en) | 1999-05-04 | 2005-11-10 | Strakan International Limited | Androgen glycosides and androgenic activity thereof |
US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6399593B1 (en) | 1999-05-04 | 2002-06-04 | Wyeth | Cyclic regimens using cyclic urea and cyclic amide derivatives |
US6423699B1 (en) | 1999-05-04 | 2002-07-23 | American Home Products Corporation | Combination therapies using benzimidazolones |
US6498154B1 (en) | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
US6358948B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
US6358947B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
US6417214B1 (en) | 1999-05-04 | 2002-07-09 | Wyeth | 3,3-substituted indoline derivatives |
US6380178B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
US6369056B1 (en) | 1999-05-04 | 2002-04-09 | American Home Products Corporation | Cyclic urea and cyclic amide derivatives |
US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
US6319912B1 (en) | 1999-05-04 | 2001-11-20 | American Home Products Corporation | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides |
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6306851B1 (en) | 1999-05-04 | 2001-10-23 | American Home Products Corporation | Cyclocarbamate and cyclic amide derivatives |
US6339098B1 (en) * | 1999-05-04 | 2002-01-15 | American Home Products Corporation | 2,1-benzisothiazoline 2,2-dioxides |
US6329416B1 (en) | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
TW593256B (en) | 1999-11-16 | 2004-06-21 | Hormos Medical Oy Ltd | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
TW200407124A (en) | 2002-06-25 | 2004-05-16 | Wyeth Corp | Use of thio-oxindole derivatives in treatment of hormone-related conditions |
TW200401637A (en) * | 2002-06-25 | 2004-02-01 | Wyeth Corp | Use of thio-oxindole derivatives in treatment of skin disorders |
US20040248989A1 (en) * | 2003-06-05 | 2004-12-09 | Risto Santti | Method for the treatment or prevention of lower urinary tract symptoms |
KR20060039867A (ko) * | 2003-06-20 | 2006-05-09 | 바이럴 게노믹스, 인크. | Hiv 치료를 위한 조성물 및 방법 |
US7247625B2 (en) * | 2003-10-09 | 2007-07-24 | Wyeth | 6-amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators |
US7323455B2 (en) * | 2004-03-24 | 2008-01-29 | Wyeth | 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators |
US7414142B2 (en) * | 2005-09-19 | 2008-08-19 | Wyeth | 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators |
US7319152B2 (en) * | 2005-09-19 | 2008-01-15 | Wyeth | 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators |
US20070066628A1 (en) * | 2005-09-19 | 2007-03-22 | Wyeth | 5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators |
WO2007135547A2 (en) * | 2006-05-22 | 2007-11-29 | Hormos Medical Ltd. | Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis |
WO2008021339A2 (en) * | 2006-08-15 | 2008-02-21 | Wyeth | Pyrrolidine and related derivatives useful as pr modulators |
WO2008021338A2 (en) * | 2006-08-15 | 2008-02-21 | Wyeth | Tricyclic oxazolidone derivatives useful as pr modulators |
US7649007B2 (en) * | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
TW200815428A (en) * | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
WO2008021309A1 (en) * | 2006-08-15 | 2008-02-21 | Wyeth | Imidazolidin-2-one derivatives useful as pr modulators |
US7538107B2 (en) | 2006-08-15 | 2009-05-26 | Wyeth | Oxazinan-2-one derivatives useful as PR modulators |
US7504530B2 (en) * | 2007-02-14 | 2009-03-17 | Hormos Medical Ltd. | Methods for the preparation of fispemifene from ospemifene |
PT2121553E (pt) * | 2007-02-14 | 2012-07-26 | Hormos Medical Ltd | Método para a preparação de derivados de trifenilbuteno com valor terapêutico |
PE20090167A1 (es) * | 2007-03-09 | 2009-02-11 | Wyeth Corp | Sintesis y caracterizacion de la forma iii polimorfica de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il)tiazol-4-il)benzonitrilo |
US20080306131A1 (en) * | 2007-06-05 | 2008-12-11 | Wyeth | Progesterone receptor modulator and uses thereof |
WO2014060639A1 (en) | 2012-10-19 | 2014-04-24 | Fermion Oy | A process for the preparation of ospemifene |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
DE3733478A1 (de) * | 1987-10-01 | 1989-04-13 | Schering Ag | Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore |
MX9301121A (es) * | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
-
1993
- 1993-10-17 DE DE4335876A patent/DE4335876A1/de not_active Withdrawn
-
1994
- 1994-10-17 HU HU9600992A patent/HUT74430A/hu unknown
- 1994-10-17 AU AU78564/94A patent/AU691839B2/en not_active Ceased
- 1994-10-17 EP EP94929553A patent/EP0723439B1/de not_active Expired - Lifetime
- 1994-10-17 ES ES94929553T patent/ES2150503T3/es not_active Expired - Lifetime
- 1994-10-17 NZ NZ274510A patent/NZ274510A/en not_active IP Right Cessation
- 1994-10-17 US US08/628,702 patent/US5719136A/en not_active Expired - Fee Related
- 1994-10-17 CN CN94194168A patent/CN1128613C/zh not_active Expired - Fee Related
- 1994-10-17 KR KR1019960701974A patent/KR100348116B1/ko not_active IP Right Cessation
- 1994-10-17 CZ CZ961111A patent/CZ285690B6/cs not_active IP Right Cessation
- 1994-10-17 DE DE59409522T patent/DE59409522D1/de not_active Expired - Fee Related
- 1994-10-17 PT PT94929553T patent/PT723439E/pt unknown
- 1994-10-17 SK SK484-96A patent/SK281312B6/sk unknown
- 1994-10-17 WO PCT/EP1994/003408 patent/WO1995011013A2/de active IP Right Grant
- 1994-10-17 AT AT94929553T patent/ATE196251T1/de not_active IP Right Cessation
- 1994-10-17 DK DK94929553T patent/DK0723439T3/da active
- 1994-10-17 JP JP7511310A patent/JPH09503774A/ja not_active Withdrawn
- 1994-10-17 CA CA002174327A patent/CA2174327C/en not_active Expired - Fee Related
-
1996
- 1996-04-16 NO NO961502A patent/NO308584B1/no unknown
-
2000
- 2000-12-12 GR GR20000402742T patent/GR3035054T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU7856494A (en) | 1995-05-08 |
EP0723439A1 (de) | 1996-07-31 |
SK48496A3 (en) | 1997-01-08 |
CN1128613C (zh) | 2003-11-26 |
CA2174327A1 (en) | 1995-04-27 |
US5719136A (en) | 1998-02-17 |
EP0723439B1 (de) | 2000-09-13 |
PT723439E (pt) | 2001-01-31 |
HU9600992D0 (en) | 1996-06-28 |
ATE196251T1 (de) | 2000-09-15 |
WO1995011013A3 (de) | 1995-06-29 |
GR3035054T3 (en) | 2001-03-30 |
DE4335876A1 (de) | 1995-04-20 |
CA2174327C (en) | 2007-05-22 |
WO1995011013A2 (de) | 1995-04-27 |
HUT74430A (en) | 1996-12-30 |
NO308584B1 (no) | 2000-10-02 |
SK281312B6 (sk) | 2001-02-12 |
AU691839B2 (en) | 1998-05-28 |
DK0723439T3 (da) | 2000-10-30 |
CZ285690B6 (cs) | 1999-10-13 |
CN1135176A (zh) | 1996-11-06 |
ES2150503T3 (es) | 2000-12-01 |
NO961502D0 (no) | 1996-04-16 |
KR100348116B1 (ko) | 2002-11-25 |
NZ274510A (en) | 2001-03-30 |
CZ111196A3 (en) | 1996-08-14 |
KR960704535A (ko) | 1996-10-09 |
NO961502L (no) | 1996-06-14 |
DE59409522D1 (de) | 2000-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09503774A (ja) | 閉経直前及び閉経後の女性に対するホルモン置換療法用の黄体ホルモン拮抗物質及び部分的アゴニスト作用を有する抗エストロゲンの組合わせ | |
KR100385663B1 (ko) | 여성피임용으로함께사용될수있는프로게스테론길항작용및항에스트로겐작용이있는화합물 | |
KR100365879B1 (ko) | 프로게스테론길항제및게스타겐을포함하는자궁내막증식증또는자궁평활근종치료제 | |
US20120225853A1 (en) | Hormone replacement therapy and depression | |
US6143754A (en) | Competitive progesterone antagonist for demand-oriented female birth control | |
JP2003511399A (ja) | 女性避妊薬の成分としてのメソプロゲスチン(プロゲステロン受容体モジュレーター) | |
CA2248841C (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
EP1605924B1 (en) | Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) | |
US7629334B1 (en) | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) | |
MXPA98007513A (en) | Sequencial combination of estrogen / antagonist of progesterone for therapy of replacement of hormo | |
AU5942700A (en) | Sequential estrogen/progestrone antagonist combination for hormone replacement theapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050315 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050614 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050725 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050706 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051004 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20051228 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060220 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20060522 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060704 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061002 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061002 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20061228 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070116 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070202 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070522 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070821 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070824 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080123 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20080228 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081118 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081125 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20090316 |